CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients
Clinical trial NCT03944902 · TERMINATED
Trial details
- NCT number
- NCT03944902
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2022-01-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.